BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 27272021)

  • 1. The interplay between effector binding and allostery in an engineered protein switch.
    Choi JH; Xiong T; Ostermeier M
    Protein Sci; 2016 Sep; 25(9):1605-16. PubMed ID: 27272021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-allosteric enzyme switches possess larger effector-induced changes in thermodynamic stability than their non-switch analogs.
    Choi JH; San A; Ostermeier M
    Protein Sci; 2013 Apr; 22(4):475-85. PubMed ID: 23400970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The high-affinity maltose switch MBP317-347 has low affinity for glucose: implications for targeting tumors with metabolically directed enzyme prodrug therapy.
    Valdes G; Schulte RW; Ostermeier M; Iwamoto KS
    Chem Biol Drug Des; 2014 Mar; 83(3):266-71. PubMed ID: 24131788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modular protein switches derived from antibody mimetic proteins.
    Nicholes N; Date A; Beaujean P; Hauk P; Kanwar M; Ostermeier M
    Protein Eng Des Sel; 2016 Feb; 29(2):77-85. PubMed ID: 26637825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro recombination of non-homologous genes can result in gene fusions that confer a switching phenotype to cells.
    Heins RA; Choi JH; Sohka T; Ostermeier M
    PLoS One; 2011; 6(11):e27302. PubMed ID: 22096548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR characterization of an engineered domain fusion between maltose binding protein and TEM1 beta-lactamase provides insight into its structure and allosteric mechanism.
    Wright CM; Majumdar A; Tolman JR; Ostermeier M
    Proteins; 2010 May; 78(6):1423-30. PubMed ID: 20034108
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure of an engineered β-lactamase maltose binding protein fusion protein: insights into heterotropic allosteric regulation.
    Ke W; Laurent AH; Armstrong MD; Chen Y; Smith WE; Liang J; Wright CM; Ostermeier M; van den Akker F
    PLoS One; 2012; 7(6):e39168. PubMed ID: 22720063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of effector affinity by hinge region mutations also modulates switching activity in an engineered allosteric TEM1 beta-lactamase switch.
    Kim JR; Ostermeier M
    Arch Biochem Biophys; 2006 Feb; 446(1):44-51. PubMed ID: 16384549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed evolution of protein switches and their application to the creation of ligand-binding proteins.
    Guntas G; Mansell TJ; Kim JR; Ostermeier M
    Proc Natl Acad Sci U S A; 2005 Aug; 102(32):11224-9. PubMed ID: 16061816
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rational design of a fusion protein to exhibit disulfide-mediated logic gate behavior.
    Choi JH; Ostermeier M
    ACS Synth Biol; 2015 Apr; 4(4):400-6. PubMed ID: 25144732
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Engineered synthetic antibodies as probes to quantify the energetic contributions of ligand binding to conformational changes in proteins.
    Mukherjee S; Griffin DH; Horn JR; Rizk SS; Nocula-Lugowska M; Malmqvist M; Kim SS; Kossiakoff AA
    J Biol Chem; 2018 Feb; 293(8):2815-2828. PubMed ID: 29321208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Creation of an allosteric enzyme by domain insertion.
    Guntas G; Ostermeier M
    J Mol Biol; 2004 Feb; 336(1):263-73. PubMed ID: 14741221
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ligand binding and allostery can emerge simultaneously.
    Liang J; Kim JR; Boock JT; Mansell TJ; Ostermeier M
    Protein Sci; 2007 May; 16(5):929-37. PubMed ID: 17400921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structurally distributed surface sites tune allosteric regulation.
    McCormick JW; Russo MA; Thompson S; Blevins A; Reynolds KA
    Elife; 2021 Jun; 10():. PubMed ID: 34132193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutations in maltose-binding protein that alter affinity and solubility properties.
    Walker IH; Hsieh PC; Riggs PD
    Appl Microbiol Biotechnol; 2010 Sep; 88(1):187-97. PubMed ID: 20535468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of protein switches based on an ensemble model of allostery.
    Choi JH; Laurent AH; Hilser VJ; Ostermeier M
    Nat Commun; 2015 Apr; 6():6968. PubMed ID: 25902417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A useful epitope tag derived from maltose binding protein.
    Lénon M; Ke N; Ren G; Meuser ME; Loll PJ; Riggs P; Berkmen M
    Protein Sci; 2021 Jun; 30(6):1235-1246. PubMed ID: 33896065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins.
    Fox JD; Kapust RB; Waugh DS
    Protein Sci; 2001 Mar; 10(3):622-30. PubMed ID: 11344330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic approach to the role of tryptophan residues in the activities and fluorescence of a bacterial periplasmic maltose-binding protein.
    Martineau P; Szmelcman S; Spurlino JC; Quiocho FA; Hofnung M
    J Mol Biol; 1990 Jul; 214(1):337-52. PubMed ID: 2196376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MBP-binding DARPins facilitate the crystallization of an MBP fusion protein.
    Gumpena R; Lountos GT; Waugh DS
    Acta Crystallogr F Struct Biol Commun; 2018 Sep; 74(Pt 9):549-557. PubMed ID: 30198887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.